Search for: "Upjohn Co., in Re" Results 61 - 80 of 87
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Sep 2011, 4:06 am by Maxwell Kennerly
Upjohn Co., 813 P.2d 89 (Utah 1991)(“We are persuaded that all prescription drugs should be classified as unavoidably dangerous in design because of th [read post]
26 May 2015, 7:42 am
  So far many plaintiffs have had trouble coming up with factual support to back such allegations – and sometimes we’re not even sure why they’re making them. [read post]
19 Sep 2013, 9:53 am by Bexis
., 712 F.3d 60 (1st Cir. 2013) – all of which also travel under the heading, In re Neurontin Marketing and Sales Practices Litigation. [read post]
27 Aug 2011, 7:55 pm
Upjohn Co., 122 F.3d 1478, 1479 (Fed. [read post]
28 Apr 2011, 3:18 pm by Bexis
 Obviously, if we’re calling California conservative and Idaho liberal, then the issues associated with comment k don’t fit well into the usual legal cubby holes.Idaho, then – holding our noses all the way. [read post]
20 Aug 2010, 3:35 pm
Upjohn Co., 122 F.3d 1476, 1483 (Fed. [read post]
27 Aug 2010, 2:41 pm by Bexis
Upjohn Co., 702 S.W.2d 566, 576 (Tenn. [read post]
17 Dec 2014, 12:38 pm by Schachtman
The use of multiple case reports as evidence of causation is analogous to the use of historical population controls: the co-occurrence of thalidomide ingestion in pregnancy and phocomelia in the offspring was evidence of causation because both thalidomide use and phocomelia were highly unusual in the population prior to the period of interest. [read post]
25 Apr 2015, 11:03 am by Schachtman
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
2 Oct 2008, 12:36 pm
Merck & Co., 2006 WL 3302574, at *3 & n.2 (S. [read post]